GFAP and nasopharyngeal carcinoma: We treated NPC during 4 days of proliferation and either 6, 8 or 10 days of differentiation (10, 12 and 14 days, respectively) with Activin A and analyzed expression of β-III Tubulin, MAP2 and GFAP by immunocytochemistry.